Results 71 to 80 of about 53,718 (156)
Background This study developed and validated a simple, robust, and cost-effective RP-HPLC bioanalytical method for the determination of nebivolol hydrochloride (NBH) and amlodipine besylate (AMB) in human plasma. Briefly, NBH and AMB were extracted from
Kaveri T. Vaditake, Atul A. Shirkhedkar
doaj +1 more source
Background Nebivolol hydrochloride (NBH) is a β-blocker known for its vasodilatory effects. According to the literature, it is commonly used to treat hypertension.
Kaveri T. Vaditake, Atul A. Shirkhedkar
doaj +1 more source
The present research is an approach to develop a formulation platform that shall help in minimizing the time and effort taken to develop a drug delivery system.
Emmanuel, C. +3 more
core +1 more source
UEG Week 2025 Poster Presentations
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley +1 more source
The voltammetric behavior of antipsychotic drugs, such as, chlorpromazine hydrochloride and promethazine hydrochloride has been investigated at a glassy carbon electrode in Britton–Robinson buffer of pH 9.
Wang, li +5 more
core +1 more source
Objective: Evidence suggests that reduction of nitric oxide (NO) bioavailability due to oxidative stress plays a central role in the pathophysiology of cerebral vasospasm after subarachnoid haemorrhage (SAH).
Turkoz, Yusuf +7 more
core +1 more source
Nebivolol in the treatment of chronic heart failure
Angie Veverka, Jennifer L SalinasWingate University School of Pharmacy, Wingate, NC, USAAbstract: Nebivolol is a highly selective beta1-adrenergic blocker that also enhances nitric oxide bioavailability via the L-arginine-nitric oxide pathway, leading to
Angie Veverka, Jennifer L Salinas
core
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation
Robert WeissAndroscoggin Cardiology Associates, Auburn, ME, USAAbstract: Nebivolol is a novel beta1-blocker with a greater degree of selectivity for beta1- adrenergic receptors than other agents in this class and a nitric oxide (NO)-potentiating ...
Robert Weiss
core
Nebivolol: Endothelium-mediated vasodilating effect
Nebivolol, a racemic mixture of (S,R,R,R) and (R,S,S,S) enantiomers, is the most beta (1)-selective adrenoceptor antagonist currently available for clinical use.
Ritter, J M
core +3 more sources
Pharmacological properties of nebivolol
Nebivolol is a third generation β1 selective beta-blocker with vasodilatory properties which is approved for the treatment of hypertension and heart failure. The vasodilatory effect is nitric-oxide mediated and activated via β3-agonism. Nebivolol has the
Komsuoğlu Çelikyurt, Feride İpek
core +1 more source

